Hidradenitis Suppurativa in a Patient Affected by Mayer-Rokitansky-Küster-Hauser Syndrome: Insight into the Role of Hormones in HS.
Hidradenitis suppurativa
Hormones
Mayer-Rokitansky-Küster-Hauser syndrome
Journal
Skin appendage disorders
ISSN: 2296-9195
Titre abrégé: Skin Appendage Disord
Pays: Switzerland
ID NLM: 101670617
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
23
04
2020
accepted:
13
05
2020
entrez:
14
12
2020
pubmed:
15
12
2020
medline:
15
12
2020
Statut:
ppublish
Résumé
Hidradenitis suppurativa (HS) is an inflammatory skin disease, which usually occurs after puberty. Even if the pathogenesis of HS is still unproven, numerous studies hypothesized that the disease is triggered by genetic and environmental factors, with hormones playing a central role. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome is a congenital malformation in which a failure of Müllerian duct development results in absent uterus and fallopian tubes and malformations of the vagina. A 38-year-old Caucasian female referred at our outpatient clinic affected by HS. Before the appearance of HS manifestations, the patient referred to a gynecologist due to difficulties in getting pregnant. The sonographic findings were consistent with MRKH syndrome. An ovarian stimulation for in vitro fertilization was started. However, after 3 months the patient showed the first HS onset. After the hormonal treatment ended, a combined treatment with rifampicin and clindamycin was started, showing a great clinical improvement at week 10. HS usually appears after puberty, exhibits premenstrual flare, improves in pregnancy, and worsens postpartum, which indicates a role of hormones and particularly of androgens in its pathophysiology. Contrasting data are reported in the literature. Our case wants to strengthen the idea that hormones could play an important role, probably with other endogenous or exogenous factors. Multidisciplinary investigations will clarify which part is played by each factor in the pathogenesis of HS.
Identifiants
pubmed: 33313053
doi: 10.1159/000508669
pii: sad-0006-0366
pmc: PMC7706494
doi:
Types de publication
Case Reports
Langues
eng
Pagination
366-369Informations de copyright
Copyright © 2020 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
None of the authors have any conflict of interest, including specific financial interests of relationships and affiliation relevant to the subject matter or discussed materials in the manuscript.
Références
Acta Dermatovenerol Croat. 2016 Dec;24(4):239-249
pubmed: 28128074
Am J Clin Dermatol. 2019 Aug;20(4):503-513
pubmed: 31073704
Arch Gynecol Obstet. 2018 Feb;297(2):513-520
pubmed: 29177592
Br J Dermatol. 1991 Oct;125(4):304-8
pubmed: 1954117
Rev Endocr Metab Disord. 2016 Sep;17(3):335-341
pubmed: 27294593
Br J Dermatol. 2019 Apr;180(4):949
pubmed: 30430549
Australas J Dermatol. 2018 Nov;59(4):267-277
pubmed: 29355905
Exp Dermatol. 2008 May;17(5):455-6; discussion 457-72
pubmed: 18400064
Can Fam Physician. 2017 Feb;63(2):114-120
pubmed: 28209676
J Cutan Med Surg. 2007 Jul-Aug;11(4):125-31
pubmed: 17601419
Expert Rev Clin Pharmacol. 2018 Sep;11(9):879-887
pubmed: 30136871
Br J Dermatol. 1986 Sep;115(3):263-8
pubmed: 2944534
Am J Dermatopathol. 2015 Feb;37(2):129-32
pubmed: 25229569
Clin Cosmet Investig Dermatol. 2017 Apr 19;10:105-115
pubmed: 28458570
J Ayub Med Coll Abbottabad. 2013 Jan-Jun;25(1-2):208-9
pubmed: 25098098
J Eur Acad Dermatol Venereol. 2015 Apr;29(4):619-44
pubmed: 25640693
J Clin Aesthet Dermatol. 2016 Jun;9(6):44-50
pubmed: 27386051
G Ital Dermatol Venereol. 2018 Jun;153(3 Suppl 2):3-7
pubmed: 30468374
Br J Surg. 1988 Oct;75(10):972-5
pubmed: 3219545
J Drugs Dermatol. 2016 Aug 1;15(8):1017-22
pubmed: 27538005